3BBLACKBIODX / Q3-FY26 / claim-ledger

Audit the questions that mattered.

3B Blackbio DX · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

WatchQ3-FY26 · 2026-02-10Back to quarter ↗

Questions audited

11

Answered directly

73%

Numeric claims

3

Consistency

mixed

Question ledger

What was answered, and how?

Sagar Tana · Alchemy Ventures

direct

Clarification on open vs closed system and new products

No, no, no, no. See, you see when we say open system, we mean reagent. So, you know, we we are supplying kits. So, we consider it as a reagent or you can say that we are into the open kits market to be very precise.

Sagar Tana · Alchemy Ventures

partial

Thoughts on closed system to keep competition away

No so we are already doing a sample to answer machine uh which is a segment by itself. So we are also developing automated extraction. We are trying to develop kits you know which are highly multiplex like our spirit panel AMR panel.

Sagar Tana · Alchemy Ventures

direct

How UK acquisition helps with products and synergies

All right. So, first let me clear, we acquired our UK distributor who was already selling our kits in UK. The object was to have those profits which a distributor was having come into the company and to have a subsidiary established in Europe specifically in UK.

Sagar Tana · Alchemy Ventures

direct

Synergies between India and Belgium operations

No. So just now because it is a recent acquisition, we are trying to make them work on a standalone basis. We are integrated. We were earlier also selling the products that they were doing.

Sagar Tana · Alchemy Ventures

direct

Cost and timeline for US FDA approvals

regulatory approvals take one to two years the moment you have the approval then you start peditating the market which is a process by itself So again to have the full effect come into the company it should be I think maybe 3 or 4 years from now.

Ganesh · Danlakshmi Investment

direct

Reason for increased competitive intensity now

I think this is a very basic question any industry which has a high margin it will have competition if you just see mobile industry where it was and where it is today so new players keep coming

Ganesh · Danlakshmi Investment

partial

Change in credit periods and metrics to avoid bad receivables

So nowadays our industry easily people are taking 3 to four months and they spill spill overs up to 5 months because lot of suppliers goes to government and the pro there the time taking process. Labs also try to take advantage of long credit cycle and competitors offer the same finance.

DHL Sha · Dalmas Capital Management

direct

One-off revenue from HAT contract and its recurrence

Yeah, the head contract the government it was 850 850 850k. So if you multiply that with 104 roughly around 8 crores also roughly around 8 crores then yeah 8.8 crores that is the one off.

DHL Sha · Dalmas Capital Management

evasive

Growth trends in domestic business and industry

I will not I will not go by quarter on quarter it's a very very because we have seasonal diseases so one quarter will be affected other won't I I would prefer to go it on a a yearly basis and a half yearly basis.

DHL Sha · Dalmas Capital Management

partial

Avenues to venture into other related businesses

we are exploring but we will keep focus on the diagnostic segments only because that's where is our experience and uh we will look for other acquisitions if if they give a better product we will take them into Indian market

Raja Narula · Individual Investor

direct

Scope of renewing HAT contract or replacing revenue

So I already answered this you know that for next two years uh at 1.5 million it should continue till that 6 billion is finished in parallel we have already started the US FDO work so most probably in one or maybe less than one and a half years we should have the US FDA work

Rani Singh · Luama Wealth and Investment Limited

partial

Current cash position post chorus deal

uh when read somewhere around 190 but exact number I won't be able to comment but somewhere around there